Zacks Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $325K | Sell |
4,528
-2,737
| -38% | -$211K | ﹤0.01% | 569 |
|
|
2025
Q4 | $577K | Buy |
7,265
+178
| +3% | +$14K | ﹤0.01% | 477 |
|
|
2025
Q3 | $534K | Buy |
+7,087
| New | +$486K | ﹤0.01% | 484 |
|
|
2025
Q2 | – | Sell |
-3,231
| Closed | -$219K | – | 711 |
|
|
2025
Q1 | $219K | Buy |
+3,231
| New | +$193K | ﹤0.01% | 599 |
|
|
2024
Q3 | – | Sell |
-4,443
| Closed | -$262K | – | 695 |
|
|
2024
Q2 | $262K | Sell |
4,443
-3,662
| -45% | -$229K | ﹤0.01% | 532 |
|
|
2024
Q1 | $646K | Sell |
8,105
-1,983
| -20% | -$151K | 0.01% | 442 |
|
|
2023
Q4 | $797K | Sell |
10,088
-155,714
| -94% | -$11.1M | 0.01% | 407 |
|
|
2023
Q3 | $11.6M | Sell |
165,802
-68,958
| -29% | -$4.89M | 0.15% | 134 |
|
|
2023
Q2 | $16.2M | Sell |
234,760
-655,049
| -74% | -$46.6M | 0.2% | 112 |
|
|
2023
Q1 | $66.1M | Buy |
889,809
+22,123
| +3% | +$1.86M | 0.89% | 32 |
|
|
2022
Q4 | $80.9M | Buy |
867,686
+32,043
| +4% | +$3.09M | 1.13% | 23 |
|
|
2022
Q3 | $79.7M | Buy |
835,643
+13,696
| +2% | +$1.36M | 1.27% | 19 |
|
|
2022
Q2 | $76.2M | Buy |
821,947
+47,757
| +6% | +$4.66M | 1.16% | 23 |
|
|
2022
Q1 | $78.4M | Buy |
774,190
+41,034
| +6% | +$4.31M | 1.09% | 27 |
|
|
2021
Q4 | $75.6M | Buy |
733,156
+15,942
| +2% | +$1.47M | 1.06% | 23 |
|
|
2021
Q3 | $60.9M | Buy |
717,214
+17,642
| +3% | +$1.48M | 0.96% | 25 |
|
|
2021
Q2 | $58.4M | Buy |
699,572
+122,804
| +21% | +$10.1M | 0.94% | 32 |
|
|
2021
Q1 | $43.4M | Sell |
576,768
-35,260
| -6% | -$2.57M | 0.77% | 43 |
|
|
2020
Q4 | $41.8M | Sell |
612,028
-47,743
| -7% | -$3.11M | 0.77% | 44 |
|
|
2020
Q3 | $38.5M | Buy |
659,771
+48,145
| +8% | +$3M | 0.78% | 40 |
|
|
2020
Q2 | $39.7M | Sell |
611,626
-21,966
| -3% | -$1.38M | 0.87% | 39 |
|
|
2020
Q1 | $37.6M | Buy |
633,592
+573,416
| +953% | +$38.3M | 0.92% | 38 |
|
|
2019
Q4 | $4.47M | Buy |
+60,176
| New | +$4.23M | 0.08% | 161 |
|
|
2016
Q4 | – | Sell |
-135,573
| Closed | -$12.1M | – | 663 |
|
|
2016
Q3 | $12.1M | Buy |
135,573
+24,061
| +22% | +$2.27M | 0.34% | 78 |
|
|
2016
Q2 | $10.7M | Sell |
111,512
-1,037
| -0.9% | -$103K | 0.33% | 81 |
|
|
2016
Q1 | $11.7M | Buy |
112,549
+11,328
| +11% | +$1.1M | 0.37% | 80 |
|
|
2015
Q4 | $9.9M | Sell |
101,221
-20,399
| -17% | -$2M | 0.32% | 91 |
|
|
2015
Q3 | $11.7M | Sell |
121,620
-1,501
| -1% | -$158K | 0.41% | 79 |
|
|
2015
Q2 | $12.9M | Buy |
123,121
+1,449
| +1% | +$148K | 0.41% | 85 |
|
|
2015
Q1 | $12.6M | Buy |
121,672
+9,072
| +8% | +$918K | 0.4% | 86 |
|
|
2014
Q4 | $10.8M | Buy |
112,600
+22,424
| +25% | +$1.98M | 0.35% | 93 |
|
|
2014
Q3 | $7.18M | Buy |
90,176
+79,946
| +781% | +$6.3M | 0.25% | 113 |
|
|
2014
Q2 | $771K | Sell |
10,230
-273
| -3% | -$20.6K | 0.03% | 313 |
|
|
2014
Q1 | $786K | Sell |
10,503
-12,274
| -54% | -$867K | 0.03% | 299 |
|
|
2013
Q4 | $1.63M | Buy |
22,777
+297
| +1% | +$19.1K | 0.06% | 186 |
|
|
2013
Q3 | $1.28M | Buy |
22,480
+374
| +2% | +$22.3K | 0.06% | 208 |
|
|
2013
Q2 | $1.26M | Buy |
+22,106
| New | +$1.28M | 0.06% | 195 |
|
Other funds holding CVS
VCM
VPM
Zacks Investment Management's CVS Position: Q1 2026 in Review
Zacks Investment Management reduced its CVS Health (CVS) stake by 38% in Q1 2026, selling an estimated $211K and leaving 4,528 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #569.
Zacks Investment Management first reported a position in CVS in Q2 2013 and has held it in 37 quarters since. The position peaked at $80.9M in Q4 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Zacks Investment Management held 4,528 shares of CVS Health worth $325K as of Q1 2026.
- Zacks Investment Management sold 2,737 CVS Health shares in Q1 2026, an estimated $211K.
- CVS Health made up ﹤0.01% of Zacks Investment Management's portfolio in Q1 2026, its #569 holding.
- Zacks Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 37 quarters since.
- Zacks Investment Management's CVS Health position peaked at $80.9M in Q4 2022.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.